CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Net revenue	$ 10,484,530	$ 12,299,010	$ 21,037,805	$ 24,431,305
Cost of revenue	5,692,958	7,214,667	11,619,367	14,220,014
Gross profit	4,791,572	5,084,343	9,418,438	10,211,291
Operating expenses:
Sales and marketing expenses:	486,544	451,961	966,422	844,762
Research and development expenses	573,229	1,102,445	1,210,358	1,621,840
General and administrative expenses	4,216,741	4,129,653	7,917,887	8,158,077
Impairment of goodwill and long-lived assets	6,763,072	0	6,763,072	0
Total operating expenses	12,039,586	5,684,059	16,857,739	10,624,679
Loss from operations	(7,248,014)	(599,716)	(7,439,301)	(413,388)
Interest expense, net	177,159	122,474	363,916	246,631
Loss before income tax benefit	(7,425,173)	(722,190)	(7,803,217)	(660,019)
Income tax benefit	(183,443)	(137,180)	(182,145)	(445,347)
Net loss	(7,241,730)	(585,010)	(7,621,072)	(214,672)
Net loss	(7,241,730)	(585,010)	(7,621,072)	(214,672)
Other comprehensive income (loss):
Foreign currency translation	(275,360)	138,552	(245,621)	78,192
Total comprehensive loss	$ (7,517,090)	$ (446,458)	$ (7,866,693)	$ (136,480)
Basic net loss per common share (in dollars per share)	$ (0.49)	$ (0.04)	$ (0.52)	$ (0.01)
Diluted net loss per common share (in dollars per share)	$ (0.49)	$ (0.04)	$ (0.52)	$ (0.01)
Weighted average shares outstanding
Basic (in shares)	14,770,943	15,002,818	14,721,733	15,091,356
Diluted (in shares)	14,770,943	15,002,818	14,721,733	15,091,356